Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Arnoud van der Laarse & Christa M. Cobbaert. (2021) Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine. Expert Review of Cardiovascular Therapy 19:12, pages 1085-1096.
Read now
Read now
Uffe Ravnskov, Abdullah Alabdulgader, Michel de Lorgeril, David M. Diamond, Rokuro Hama, Tomohito Hamazaki, Björn Hammarskjöld, Zoe Harcombe, Malcolm Kendrick, Peter Langsjoen, Kilmer S. McCully, Harumi Okuyama, Sherif Sultan & Ralf Sundberg. (2020) The new European guidelines for prevention of cardiovascular disease are misleading. Expert Review of Clinical Pharmacology 13:12, pages 1289-1294.
Read now
Read now
Uffe Ravnskov, Michel de Lorgeril, David M Diamond, Rokuro Hama, Tomohito Hamazaki, Björn Hammarskjöld, Niamh Hynes, Malcolm Kendrick, Peter H Langsjoen, Luca Mascitelli, Kilmer S McCully, Harumi Okuyama, Paul J Rosch, Tore Schersten, Sherif Sultan & Ralf Sundberg. (2018) LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature. Expert Review of Clinical Pharmacology 11:10, pages 959-970.
Read now
Read now
Tamás Ferenci. (2017) Absolute risk reduction may depend on the duration of the follow-up. Expert Review of Clinical Pharmacology 10:12, pages 1409-1410.
Read now
Read now
Fred Young Phillips & Deog-Seong Oh. (2016) Technology assessment and the social and human impact of innovation. Bulletin of the Atomic Scientists 72:6, pages 402-411.
Read now
Read now
Articles from other publishers (43)
George Winter. (2023) Statins and risk. Journal of Prescribing Practice 5:7, pages 278-279.
Crossref
Crossref
Ronald B. Brown. (2023) Polypharmacy and Medication Outcome Reporting Bias in Older Patients with COVID-19. BioMed 3:3, pages 320-328.
Crossref
Crossref
Reinhard Waehler. (2023) Fatty acids: facts vs. fiction. International Journal for Vitamin and Nutrition Research 93:3, pages 268-288.
Crossref
Crossref
Juan Liu, Xinrui Zhou, Chao Feng, Wenfang Zheng, Pu Chen, Xiaozhi Zhang & Peng Hou. (2023) Glucagon-modified Liposomes Delivering Thyroid Hormone for Anti-obesity Therapy. Archives of Medical Research 54:4, pages 287-298.
Crossref
Crossref
David M Diamond & Paul E Leaverton. (2023) Historical Review of the Use of Relative Risk Statistics in the Portrayal of the Purported Hazards of High LDL Cholesterol and the Benefits of Lipid-Lowering Therapy. Cureus.
Crossref
Crossref
Léo Fernandes Pereira & Charles Dalcanale Tesser. (2023) O sofrimento futuro pode ser evitado: o yoga como estratégia na prevenção primária das doenças cardiovasculares. Physis: Revista de Saúde Coletiva 33.
Crossref
Crossref
Michael Georgoulis, Christina Chrysohoou, Ekavi Georgousopoulou, Evangelia Damigou, Ioannis Skoumas, Christos Pitsavos & Demosthenes Panagiotakos. (2022) Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002–2012). Lipids in Health and Disease 21:1.
Crossref
Crossref
David M. Diamond, Benjamin T. Bikman & Paul Mason. (2022) Statin therapy is not warranted for a person with high LDL-cholesterol on a low-carbohydrate diet. Current Opinion in Endocrinology, Diabetes & Obesity 29:5, pages 497-511.
Crossref
Crossref
Uffe Ravnskov, Michel de Lorgeril, Malcolm Kendrick & David M. Diamond. (2022) Importance of Coagulation Factors as Critical Components of Premature Cardiovascular Disease in Familial Hypercholesterolemia. International Journal of Molecular Sciences 23:16, pages 9146.
Crossref
Crossref
A. P. Vasiliev & N. N. Streltsova. (2022) Cholesterol and its biological significance. Atherosclerosis. Statin therapy (Part 2). The Siberian Journal of Clinical and Experimental Medicine 37:2, pages 13-20.
Crossref
Crossref
Uffe Ravnskov & Kilmer S. McCully. (2022) Commentary: Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential. Frontiers in Oncology 12.
Crossref
Crossref
Paula Byrne, Maryanne Demasi, Mark Jones, Susan M. Smith, Kirsty K. O’Brien & Robert DuBroff. (2022) Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment. JAMA Internal Medicine 182:5, pages 474.
Crossref
Crossref
Lee Sandwith & Patrice Forget. (2021) Statins in Healthy Adults: A Meta-Analysis. Medicina 57:6, pages 585.
Crossref
Crossref
Jean‐Pierre Montani. (2021) Ancel Keys: The legacy of a giant in physiology, nutrition, and public health. Obesity Reviews 22:S2.
Crossref
Crossref
Giampaolo Minetti. (2020) Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: Reasoning about connections. Medical Hypotheses 144, pages 110128.
Crossref
Crossref
Handrean Soran, Michael France, Safwaan Adam, Zohaib Iqbal, Jan H. Ho & Paul N. Durrington. (2020) Quantitative evaluation of statin effectiveness versus intolerance and strategies for management of intolerance. Atherosclerosis 306, pages 33-40.
Crossref
Crossref
A. I. Dyadyk, T. E. Kugler, S. R. Zborowskyy & Yu. V. Suliman. (2019) Statin-associated muscle symptoms: epidemiology, risk factors, mechanisms and treatment. Kardiologiia 59:5S, pages 4-12.
Crossref
Crossref
Al-alawy Khamis. (2019) Overcoming the health system challenges in the 21st century and beyond?. Public Health 168, pages 47-49.
Crossref
Crossref
David M. Diamond, Michel de Lorgeril, Malcolm Kendrick, Uffe Ravnskov & Paul J. Rosch. (2019) Formal comment on “Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease”. PLOS ONE 14:1, pages e0205138.
Crossref
Crossref
Charles Dalcanale Tesser & Armando Henrique Norman. (2019) Geoffrey Rose e o princípio da precaução: para construir a prevenção quaternária na prevenção. Interface - Comunicação, Saúde, Educação 23.
Crossref
Crossref
Matyas Szigeti, Levente Kovacs & Tamas Ferenci. (2019) Stability of relative and absolute metrics: empirical evidence from pulmonology. Stability of relative and absolute metrics: empirical evidence from pulmonology.
Ioannis Zabetakis, Ronan Lordan & Alexandros Tsoupras. 2019. The Impact of Nutrition and Statins on Cardiovascular Diseases. The Impact of Nutrition and Statins on Cardiovascular Diseases
289
317
.
Sherif Sultan, Ashwini D'Souza, Ioannis Zabetakis, Ronan Lordan, Alexandros Tsoupras, Edel P. Kavanagh & Niamh Hynes. 2019. The Impact of Nutrition and Statins on Cardiovascular Diseases. The Impact of Nutrition and Statins on Cardiovascular Diseases
171
200
.
I. M. Y. van Vliet, K. Boslooper-Meulenbelt & G. J. Navis. 2019. Informatorium voor Voeding en Diëtetiek – Supplement 101 – april 2019. Informatorium voor Voeding en Diëtetiek – Supplement 101 – april 2019
101
112
.
Uffe Ravnskov, Michel de Lorgeril, Malcolm Kendrick & David M. Diamond. (2018) Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia. Medical Hypotheses 121, pages 60-63.
Crossref
Crossref
Handrean Soran, Safwaan Adam & Paul N. Durrington. (2018) Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk. Atherosclerosis 278, pages 135-142.
Crossref
Crossref
A. I. Dyadyk, T. E. Kugler, Y. V. Suliman, S. R. Zborovskyy & I. I. Zdykhovskaya. (2018) STATIN ADVERSE EFFECTS: MECHANISMS, DIAGNOSIS, PREVENTION AND MANAGEMENT. The Russian Archives of Internal Medicine 8:4, pages 266-276.
Crossref
Crossref
George Winter. (2018) The divided medical opinions of the statin debate updated. British Journal of Healthcare Management 24:7, pages 318-319.
Crossref
Crossref
Siril S. Bakke, Marie H. Aune, Nathalie Niyonzima, Katrine Pilely, Liv Ryan, Mona Skjelland, Peter Garred, Pål Aukrust, Bente Halvorsen, Eicke Latz, Jan K. Damås, Tom E. Mollnes & Terje Espevik. (2017) Cyclodextrin Reduces Cholesterol Crystal–Induced Inflammation by Modulating Complement Activation. The Journal of Immunology 199:8, pages 2910-2920.
Crossref
Crossref
Michael Sampson. (2017) Pills or push-ups?. British Journal of Cardiac Nursing 12:8, pages 369-369.
Crossref
Crossref
Mamadou Diop, Julie Fiset-Laniel, Sylvie Provost, Pierre Tousignant, Roxane Borgès Da Silva, Marie-Jo Ouimet, Eric Latimer & Erin Strumpf. (2017) Does enrollment in multidisciplinary team-based primary care practice improve adherence to guideline-recommended processes of care? Quebec’s Family Medicine Groups, 2002–2010. Health Policy 121:4, pages 378-388.
Crossref
Crossref
Emile R. Zakiev, Nikita G. Nikiforov & Alexander N. Orekhov. (2017) Cell-Based Models for Development of Antiatherosclerotic Therapies. BioMed Research International 2017, pages 1-8.
Crossref
Crossref
A.C. Liwa, E.N. Barton, W.C. Cole & C.R. Nwokocha. 2017. Pharmacognosy. Pharmacognosy
315
336
.
Rory Collins, Christina Reith, Jonathan Emberson, Jane Armitage, Colin Baigent, Lisa Blackwell, Roger Blumenthal, John Danesh, George Davey Smith, David DeMets, Stephen Evans, Malcolm Law, Stephen MacMahon, Seth Martin, Bruce Neal, Neil Poulter, David Preiss, Paul Ridker, Ian Roberts, Anthony Rodgers, Peter Sandercock, Kenneth Schulz, Peter Sever, John Simes, Liam Smeeth, Nicholas Wald, Salim Yusuf & Richard Peto. (2016) Interpretation of the evidence for the efficacy and safety of statin therapy. The Lancet 388:10059, pages 2532-2561.
Crossref
Crossref
Alexander N. Orekhov & Ekaterina A. Ivanova. (2016) Cellular models of atherosclerosis and their implication for testing natural substances with anti-atherosclerotic potential. Phytomedicine 23:11, pages 1190-1197.
Crossref
Crossref
Brian Finan, Christoffer Clemmensen, Zhimeng Zhu, Kerstin Stemmer, Karine Gauthier, Luisa Müller, Meri De Angelis, Kristin Moreth, Frauke Neff, Diego Perez-Tilve, Katrin Fischer, Dominik Lutter, Miguel A. Sánchez-Garrido, Peng Liu, Jan Tuckermann, Mohsen Malehmir, Marc E. Healy, Achim Weber, Mathias Heikenwalder, Martin Jastroch, Maximilian Kleinert, Sigrid Jall, Sara Brandt, Frédéric Flamant, Karl-Werner Schramm, Heike Biebermann, Yvonne Döring, Christian Weber, Kirk M. Habegger, Michaela Keuper, Vasily Gelfanov, Fa Liu, Josef Köhrle, Jan Rozman, Helmut Fuchs, Valerie Gailus-Durner, Martin Hrabě de Angelis, Susanna M. Hofmann, Bin Yang, Matthias H. Tschöp, Richard DiMarchi & Timo D. Müller. (2016) Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease. Cell 167:3, pages 843-857.e14.
Crossref
Crossref
Thomas R. Wood, Robert Hansen, Axel F. Sigurðsson & Guðmundur F. Jóhannsson. (2016) The cardiovascular risk reduction benefits of a low-carbohydrate diet outweigh the potential increase in LDL-cholesterol. British Journal of Nutrition 115:6, pages 1126-1128.
Crossref
Crossref
A.N. Orekhov, E.A. Ivanova & Y.V. Bobryshev. 2016. Handbook of cholesterol. Handbook of cholesterol
89
100
.
P.J. Rosch. 2016. Handbook of cholesterol. Handbook of cholesterol
375
396
.
Paal R?iri. (2016) Re: Hjerteinfarkt, mettet fett og kolesterol. Tidsskrift for Den norske legeforening 136:18, pages 1508-1508.
Crossref
Crossref
Aysha Mendes. (2015) Cholesterol and controversy: The statin conundrum. Nurse Prescribing 13:12, pages 578-579.
Crossref
Crossref
Frederick M. Stanley, Kathryn M. Linder & Timothy J. Cardozo. (2015) Statins Increase Plasminogen Activator Inhibitor Type 1 Gene Transcription through a Pregnane X Receptor Regulated Element. PLOS ONE 10:9, pages e0138097.
Crossref
Crossref
James Signy & Mark Signy. (2015) The IMPROVE-IT study and ezetimibe. British Journal of Community Nursing 20:5, pages 243-244.
Crossref
Crossref